Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta‐analysis
Abigail K. Rose, Andrew Jones
Addiction (2018) Vol. 113, Iss. 8, pp. 1396-1406
Closed Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Ultrasound‐Activated Sensitizers and Applications
Xiahui Lin, Jibin Song, Xiaoyuan Chen, et al.
Angewandte Chemie International Edition (2019) Vol. 59, Iss. 34, pp. 14212-14233
Closed Access | Times Cited: 369
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
Shari S. Rogal, Ada O. Youk, Hongwei Zhang, et al.
Hepatology (2019) Vol. 71, Iss. 6, pp. 2080-2092
Open Access | Times Cited: 160
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 110
Hazardous drinking and alcohol use disorders
James MacKillop, Roberta Agabio, Sarah W. Feldstein Ewing, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 93
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement
Roberta Agabio, Julia Sinclair, Giovanni Addolorato, et al.
The Lancet Psychiatry (2018) Vol. 5, Iss. 12, pp. 957-960
Open Access | Times Cited: 116
Diversity of structure and function of GABA<sub>B</sub> receptors: a complexity of GABA<sub>B</sub>-mediated signaling
Miho Terunuma
Proceedings of the Japan Academy Series B (2018) Vol. 94, Iss. 10, pp. 390-411
Open Access | Times Cited: 115
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Lara A. Ray, Spencer Bujarski, Erica N. Grodin, et al.
The American Journal of Drug and Alcohol Abuse (2018) Vol. 45, Iss. 2, pp. 124-140
Open Access | Times Cited: 114
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I‐Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5170-5170
Open Access | Times Cited: 103
Binding of clozapine to the GABAB receptor: clinical and structural insights
Pramod C. Nair, Ross A. McKinnon, John O. Miners, et al.
Molecular Psychiatry (2020) Vol. 25, Iss. 9, pp. 1910-1919
Closed Access | Times Cited: 72
Baclofen for alcohol use disorder
Roberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
Renaud de Beaurepaire, Julia Sinclair, Mathis Heydtmann, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 70
Baclofen for alcohol use disorder
Silvia Minozzi, Rosella Saulle, Susanne Rösner
Cochrane library (2018) Vol. 2018, Iss. 11
Open Access | Times Cited: 66
Baclofen for alcohol use disorder—a systematic meta‐analysis
Tom Bschor, Jonathan Henssler, Martín Müller, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 3, pp. 232-242
Closed Access | Times Cited: 66
The Cambridge Handbook of Substance and Behavioral Addictions
Steve Sussman, Steve Sussman, Wilson M. Compton, et al.
Cambridge University Press eBooks (2020)
Open Access | Times Cited: 63
Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial
James C. Garbutt, Alexei B. Kampov‐Polevoy, Cort A. Pedersen, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 13, pp. 2250-2256
Open Access | Times Cited: 54
Advances in the understanding and management of alcohol-related liver disease
Mark Thursz, Anne Lingford‐Hughes
BMJ (2023), pp. e077090-e077090
Closed Access | Times Cited: 16
Baclofen in the treatment of alcohol use disorder: tailored doses matter
Renaud de Beaurepaire, Philippe Jaury
Alcohol and Alcoholism (2024) Vol. 59, Iss. 2
Open Access | Times Cited: 7
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Dina Ali, H. Mokdad Ali, Matthew R. Lopez, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 318-318
Open Access | Times Cited: 6
Anticraving therapy for alcohol use disorder: A clinical review
Winston W. Shen
Neuropsychopharmacology Reports (2018) Vol. 38, Iss. 3, pp. 105-116
Open Access | Times Cited: 48
The Prevention and Treatment of Gambling Disorders: Some Art, Some Science
Jeffrey L. Derevensky
Cambridge University Press eBooks (2020), pp. 241-253
Closed Access | Times Cited: 46
Behavioral Economic Considerations of Novel Addictions and Nonaddictive Behavior: Research and Analytic Methods
Derek D. Reed, Gideon P. Naudé, Brett W. Gelino, et al.
Cambridge University Press eBooks (2020), pp. 73-86
Closed Access | Times Cited: 46
Mindfulness-Based Interventions Applied to Addiction Treatments
Afton Kechter, David S. Black
Cambridge University Press eBooks (2020), pp. 409-417
Closed Access | Times Cited: 44
Considering the Overlap and Nonoverlap of Compulsivity, Impulsivity, and Addiction
Austin W. Blum, Jon E. Grant
Cambridge University Press eBooks (2020), pp. 373-385
Closed Access | Times Cited: 44
Neurobiological Foundations of Behavioral Addictions
Steve Sussman
Cambridge University Press eBooks (2020), pp. 136-151
Closed Access | Times Cited: 44
Multiple Memory Systems, Addiction, and Health Habits: New Routes for Translational Science
Alan W. Stacy, James Russell Pike, Anna Yu Lee
Cambridge University Press eBooks (2020), pp. 152-170
Closed Access | Times Cited: 44
Page 1 - Next Page

Scroll to top